July 10, 2024 — Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal ...
In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular ...
July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...
July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading ...
July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...
July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...
On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
July 24, 2024 — During the American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024, BCVS ...
July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
July 3, 2024 —Jon Kobashigawa, MD, director of the Heart Transplant Program in the Department of Cardiology in the Smidt ...
July 2, 2024 — Biotronik announced the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro ...
July 2, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott has issued a correction for its ...
July 10, 2024
